The CT-Luso Project has been highlighted by Global Health EDCTP3 as an example of cooperation among Portuguese-speaking African countries to strengthen health research and national capacities in research ethics and clinical research regulation.
In an [article published on 29 July], Global Health EDCTP3 highlights that language remains a barrier to access to specialised training and participation in international research networks for many professionals from the Portuguese-speaking African countries (PALOP). In this context, CT-Luso is presented as a response to this challenge, providing advanced training in Portuguese, strengthening national capacities and fostering collaboration among the partner countries.
The recognition by Global Health EDCTP3 highlights the role of Lusophone cooperation in building sustainable capacity and harmonising good practices, helping to create the conditions for the PALOP to become better prepared to conduct and host high-quality clinical research in accordance with the highest ethical and scientific standards.
Coordinated by the Portuguese Pharmaceutical Society and funded by Global Health EDCTP3, CT-Luso brings together institutions from Angola, Cabo Verde, Guinea-Bissau, Mozambique, São Tomé and Príncipe and Portugal, involving their respective National Ethics Authorities, National Regulatory Authorities, universities, research centres and national health institutes, in partnership with Portuguese institutions specialising in research ethics, research regulation and clinical trials.
